New Delhi, Oct. 12 (PTI): The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough syrups, official sources here said. They said after examining and analysing the adverse event reports, causal relationship and all related details shared by or to be shared by the World Health Organization, the committee will advise and recommend further course of action to the Drugs Controller General of India (DCGI). The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals, and asked it to explain within a week “many contraventions” found during a recent inspection, or face suspension or cancellation of license. The order to halt production came days after the World Health Organization (WHO) potentially linked four cough syrups ma
Gambia Cough Syrup Deaths: Maiden Pharmaceuticals Releases Statement saying that they are awaiting results from the CDSCO on the safety of their cough syrups that have been linked to the deaths of 66 children in the Gambia by the WHO last week.
The Central Drugs Standard Control Organisation (CDSCO) has sent the samples of the same batch of the four Maiden Pharmaceuticals Ltd-manufactured medicines, on which the WHO issued alert,